Advertisement

Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x100px
Organisation › Details

Sino Biopharm (Group)

Sino Biopharm, together with its subsidiaries, is a leading, innovative research and development driven pharmaceutical conglomerate in China, with a business scope that is vertically integrated including research and development, manufacturing and sales and marketing infrastructure. The Company’s product offerings include a variety of biologics and small molecule drugs, and in therapy areas that include hepatology, oncology, cardiovascular and cerebrovascular diseases, orthopaedics, digestive and immune and respiratory diseases. *

 

Period Start 2020-03-16 existent
Products Industry pharmaceutical
  Industry 2 drug discovery
     
Region Region China_oo
  Country China
  City n. a. 
    Address record changed: 2022-06-27
     
Basic data Employees n. a.
     
    * Document for »About Section«: F-Star Therapeutics, Inc.. (6/23/22). "Press Release: invoX Pharma to Acquire F-star Therapeutics, Inc. a Pioneering Next Generation Bispecific Discovery Platform and Clinical Programs". London.
     
   
Record changed: 2023-07-10

Advertisement

Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

More documents for Sino Biopharm (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x300px




» top